Marshall Wace North America’s Ascendis Pharma A/S ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$18M	Buy	113,146 +108,454	+2,311%	+$14.8M	0.08%	250
2021 Q2	$617K	Sell	4,692 -172,020	-97%	-$22.9M	﹤0.01%	1123
2021 Q1	$22.8M	Sell	176,712 -91,386	-34%	-$13.9M	0.09%	232
2020 Q4	$44.7M	Buy	268,098 +56,684	+27%	+$9.37M	0.2%	124
2020 Q3	$32.6M	Buy	211,414 +60,923	+40%	+$8.76M	0.21%	125
2020 Q2	$22.3M	Sell	150,491 -31,020	-17%	-$4.26M	0.15%	156
2020 Q1	$20.4M	Sell	181,511 -290,108	-62%	-$37.7M	0.15%	153
2019 Q4	$65.6M	Sell	471,619 -356,893	-43%	-$39.6M	0.32%	87
2019 Q3	$79.8M	Sell	828,512 -45,133	-5%	-$5.03M	0.45%	66
2019 Q2	$101M	Sell	873,645 -287,831	-25%	-$34.4M	0.62%	41
2019 Q1	$137M	Buy	1,161,476 +418,717	+56%	+$36.7M	0.97%	22
2018 Q4	$46.5M	Buy	742,759 +39,672	+6%	+$2.49M	0.45%	65
2018 Q3	$49.8M	Buy	703,087 +63,540	+10%	+$4.37M	0.34%	80
2018 Q2	$42.5M	Buy	639,547 +66,676	+12%	+$4.38M	0.24%	104
2018 Q1	$37.5M	Buy	572,871 +206,627	+56%	+$11.6M	0.19%	127
2017 Q4	$14.7M	Sell	366,244 -88,241	-19%	-$3.21M	0.08%	290
2017 Q3	$16.4M	Buy	454,485 +280,131	+161%	+$8.04M	0.11%	255
2017 Q2	$4.88M	Sell	174,354 -5,001	-3%	-$132K	0.04%	506
2017 Q1	$5.02M	Buy	+179,355	New	+$4.53M	0.04%	393